Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

Clinical trial NCT00411723 · UNKNOWN

Trial details

NCT number: NCT00411723
Sponsor: Artielle ImmunoTherapeutics
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting

Start date: 2006-12-01
Primary completion: 2009-02-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.